These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 6113794
1. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant. Fahey MR, Morris RB, Miller RD, Sohn YJ, Cronnelly R, Gencarelli P. Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794 [Abstract] [Full Text] [Related]
7. Intubating conditions with ORG NC45. A preliminary study. Harrison P, Feldman SA. Anaesthesia; 1981 Sep; 36(9):874-7. PubMed ID: 6118074 [Abstract] [Full Text] [Related]
8. Onset time and duration of action for atracurium, Org NC45 and pancuronium. Gramstad L, Lilleaasen P, Minsaas B. Br J Anaesth; 1982 Aug; 54(8):827-30. PubMed ID: 6125161 [Abstract] [Full Text] [Related]
9. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia. Engbaek J, Ording H, Pedersen T, Viby-Mogensen J. Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154 [Abstract] [Full Text] [Related]
10. Org-NC45: a new steroidal non-depolarizing muscle relaxant. Booij LH, Vree TB, Crul JE. Pharm Weekbl Sci; 1982 Feb 19; 4(1):1-4. PubMed ID: 6122196 [Abstract] [Full Text] [Related]
11. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45. Krieg N, Mazur L, Booij LH, Crul JF. Acta Anaesthesiol Scand; 1980 Oct 19; 24(5):423-5. PubMed ID: 6110303 [Abstract] [Full Text] [Related]
12. A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium. Son SL, Waud BE, Waud DR. Anesthesiology; 1981 Jul 19; 55(1):12-8. PubMed ID: 6113793 [Abstract] [Full Text] [Related]
14. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. Marshall IG, Gibb AJ, Durant NN. Br J Anaesth; 1983 Aug 19; 55(8):703-14. PubMed ID: 6136285 [Abstract] [Full Text] [Related]
15. Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques. Fisher DM, Fahey MR, Cronnelly R, Miller RD. Anesthesiology; 1982 Oct 19; 57(4):309-10. PubMed ID: 6127044 [Abstract] [Full Text] [Related]
17. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine. Gencarelli PJ, Miller RD. Br J Anaesth; 1982 Jan 19; 54(1):53-6. PubMed ID: 6119998 [Abstract] [Full Text] [Related]
18. Stable muscle relaxation during abdominal surgery using combined intravenous bolus and demand infusion: clinical appraisal with ORG NC45. d'Hollander AA, Czerucki R, Deville A, Cuvelier F. Can Anaesth Soc J; 1982 Mar 19; 29(2):136-41. PubMed ID: 6121614 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure. Fahey MR, Morris RB, Miller RD, Nguyen TL, Upton RA. Br J Anaesth; 1981 Oct 19; 53(10):1049-53. PubMed ID: 6117300 [Abstract] [Full Text] [Related]
20. The effects of hypercarbia and hypocarbia on pancuronium and vecuronium neuromuscular blockades in anesthetized humans. Gencarelli PJ, Swen J, Koot HW, Miller RD. Anesthesiology; 1983 Nov 19; 59(5):376-80. PubMed ID: 6139044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]